At a Glance
Dosage
oral
| Level | NM-2-AI | 3,4-CTMP |
|---|---|---|
| Threshold | 5 mg | 2 mg |
| Light | 50–100 mg | 2–4 mg |
| Common | 100–150 mg | 4–6 mg |
| Strong | 150–200 mg | 6–8 mg |
| Heavy | 200 mg | 8 mg |
Duration
oral
NM-2-AI
oral
Total: 2 hrs – 4 hrsOnset
Onset30 min – 1 hrs
3,4-CTMP
oral
Total: 6 hrs – 18 hrsAfterglow
Onset1 hrs – 2 hrs
Afterglow2 hrs – 24 hrs
Effects
Safety
Interaction: NM-2-AI + 3,4-CTMP
No direct interaction data available between these substances. This does not mean the combination is safe.
NM-2-AI — Dangerous Interactions
3,4-CTMP — Dangerous Interactions
Frequently Asked Questions
What is the difference between NM-2-AI and 3,4-CTMP?
NM-2-AI is classified as a Stimulants (Amphetamine, Aminoindane) while 3,4-CTMP is classified as a Stimulants (Substituted phenidates). They share 20 effects in common, with 3 effects unique to NM-2-AI and 24 unique to 3,4-CTMP.
Is it safe to combine NM-2-AI and 3,4-CTMP?
There is no direct interaction data available for combining NM-2-AI and 3,4-CTMP. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, NM-2-AI or 3,4-CTMP?
At common doses via oral, NM-2-AI is typically dosed at 100–150 mg while 3,4-CTMP is dosed at 4–6 mg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.